Clinical Trial Analysis
Insights for "A"
Overview
Total Trials
81,743
All registered studies
Active Recruiting
22,791
27.9%
Currently enrolling patients
Completed
57,606
70.5%
Studies finished
Phase 3 Studies
14.0%
Advanced phase trials
Key Insights
Leading Region
USA
Most active geographical area
Top Organization
Hoffmann-La Roche
Most active research sponsor
Distribution Analysis
Study Phases
Trial distribution by development phase
Not Applicable
29,98636.7%
Phase 1
19,08823.4%
Phase 2
14,93318.3%
Phase 3
11,47914.0%
Phase 4
5,3796.6%
Early Phase 1
8781.1%
Not Applicable
29,98636.7%
Phase 1
19,08823.4%
Phase 2
14,93318.3%
Phase 3
11,47914.0%
Phase 4
5,3796.6%
Early Phase 1
8781.1%
Recruitment Status
Current enrollment and completion status
Total: 99,388
Geographic & Sponsor Analysis
Geographic Distribution
Trial activity by country
Top Sponsors
Most active research organizations
Rank
Company
Count
1
Hoffmann-La Roche
1621
2
Pfizer
1553
3
Eli Lilly and Company
1425
4
Novo Nordisk A/S
1299
5
GlaxoSmithKline
1197
6
AstraZeneca
922
7
Merck Sharp & Dohme LLC
893
8
Janssen Research & Development, LLC
723
9
National Institute of Allergy and Infectious Diseases (NIAID)
716
10
Bristol-Myers Squibb
700
Medical Focus Areas
Medical Conditions
Most studied disease areas
Rank
Condition
Count
1
Healthy
3107
2
Breast Cancer
1487
3
Obesity
1250
4
HIV Infections
1199
5
Diabetes Mellitus, Type 2
1161
6
Healthy Volunteers
1064
7
Diabetes
968
8
Cancer
764
9
Asthma
709
10
Rheumatoid Arthritis
692
Treatment Types
Most common interventions
Rank
Intervention
Count
1
Placebo
9697
2
Carboplatin
443
3
Pembrolizumab
442
4
Paclitaxel
404
5
Cyclophosphamide
371
6
Cisplatin
345
7
Gemcitabine
332
8
Dexamethasone
305
9
Bevacizumab
294
10
Rituximab
284